Brief: BB Biotech H1 Net Profit Down At CHF 349 Mln
July 23 (Reuters) - BB Biotech AG BION.S :
* NET PROFIT FOR PERIOD ENDED JUNE 30, 2021 AMOUNTED TO CHF
349 MN
(PROFIT OF CHF 422 MN IN H1 2020)
* IN Q2 A PROFIT OF CHF 129 MN (PROFIT OF CHF 1'180 MN IN
CORRESPONDING PERIOD OF PREVIOUS YEAR) WAS INCURRED
Source text for Eikon: ID:nEQ40Jb3Fa
Further company coverage: BION.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM